Drug repurposing for rare: progress and opportunities for the rare disease community
Repurposing is one of the key opportunities to address the unmet rare diseases therapeutic need. Based on cases of drug repurposing in small population conditions, and previous work in drug repurposing, we analyzed the most important lessons learned, such as the sharing of clinical observations, rea...
Main Authors: | Anneliene Hechtelt Jonker, Daniel O’Connor, Maria Cavaller-Bellaubi, Christine Fetro, Maria Gogou, Peter A. C. ’T Hoen, Martin de Kort, Heather Stone, Nivedita Valentine, Anna Maria Gerdina Pasmooij |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-01-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2024.1352803/full |
Similar Items
-
How to START? Four pillars to optimally begin your orphan drug development
by: Anneliene Hechtelt Jonker, et al.
Published: (2023-08-01) -
The use or generation of biomedical data and existing medicines to discover and establish new treatments for patients with rare diseases – recommendations of the IRDiRC Data Mining and Repurposing Task Force
by: Noel T Southall, et al.
Published: (2019-10-01) -
A full-document analysis of the semantic relation between European Public Assessment Reports and EMA guidelines using a BERT language model
by: Erik Bergman, et al.
Published: (2023-01-01) -
Recommendations for the design of small population clinical trials
by: Simon Day, et al.
Published: (2018-11-01) -
Model consent clauses for rare disease research
by: Minh Thu Nguyen, et al.
Published: (2019-08-01)